Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Lung Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Lung Cancer
    TopAbstracts in Lung Cancer 11/12/2008 - (DGNews)
    Circulating Plasma DNA Is a Noninvasive Marker of Early Central-Airway Cancer: Presented at CHEST - (DGDispatch)
    Minimally Invasive Surgery Effective for Stage I Non-Small-Cell Lung Cancer: Presented at CHEST - (DGDispatch)
    TopAbstracts in Lung Cancer 10/29/2008 - (DGNews)
    Invasive Pneumococcal Disease Occurs At a Higher Frequency in Cancer Patients: Presented at ICAAC/IDSA - (DGDispatch)

    News archive

     Recent webcasts/CME - Lung Cancer
    • Latest Data From Chicago Provide New Insight Into the Evolving Role of Cytotoxic and Targeted Therapies in Early-Stage NSCLC
    • Alpha1-Antitrypsin Deficiency: Incidence, Screening, and Management
    • Early Detection of Alpha1-Antitrypsin (AAT) Deficiency Helps Prevent Disease Progression
    • What Is the Best Approach to Treating Alpha1-Antitrypsin (AAT) Deficiency?
    • Silica-Related Lung Disease: It's Still Here

      Webcasts/CME archive

       Recent cases - Lung Cancer
        Diverse Histologic Appearances in Pulmonary Mucinous Cystic Neoplasia: A Case Report
        Extrapulmonary Small Cell Sarcinoma: Involvement of the Brain Without Evidence of Extracranial Malignancy by Serial PET/CT Scans
        Neurocognitive Deficits in a Patient with Small Cell Lung Cancer: A Case Report
        Hypertrophic Pulmonary Osteoarthropathy Secondary to Bronchial Adenocarcinoma and Coexisting Pulmonary Tuberculosis: A Case Report
        Double Primary Bronchogenic Carcinoma of the Lung and Papillary Thyroid Carcinoma: A Case Report

        Cases archive
          




        my personal edition > lung cancer > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Tumour Infiltrating Lymphocytes May Infer Good Prognoses in Some Cancer Patients: Presented at STS

        By Ed Susman

        FORT LAUDERDALE, FL -- February 4, 2008 -- By studying the levels of tumour-infiltrating lymphocytes in specimens of cancers, it might be possible to develop strong indicators of prognosis, researchers reported here at the Society of Thoracic Surgeons 44th Annual Meeting (STS).

        "In this study we were just trying to make correlations between the tumour-infiltrating lymphocytes and cancers," said Enrico Ruffini, MD, Associate Professor of Thoracic Surgery, University of Torino, Torino, Italy, in an oral presentation on January 29.

        Dr. Ruffini noted that some of the tumour-infiltrating lymphocytes (TILs) may fight the tumour, such as CD8-positive cells, while other cells such as CD4-positive cells may promote and restrict tumour growth.

        "We are just starting to understand which of the TILs we can use against the tumour," he said. "These preliminary results may target further molecular analysis on TIL in lung neoplasms."

        "TILs migrate inside and around the tumour -- some acting pro tumour growth and some against tumour growth. The relation between the host and the tumour cells is very complex," he noted.

        Dr. Ruffini attempted to correlate pathological findings with information about the type of tumour and the relationship with host survival. He evaluated 1,290 specimens taken from more than 2,000 patients who had cancer surgery performed between 1993 and 2006. The specimens were examined and stained through conventional histology.

        A specimen was deemed to be TIL positive if the pathologist could demonstrate there were at least 20 TILs in 10 high-powered fields examined, he explained.

        "Overall prevalence was 22%," Dr. Ruffini said, with TIL counts significantly higher in non-small-cell adenocarcinoma and squamous lung cancers (24%) when compared with neuroendocrine tumours (5%)." He also saw correlations between higher concentrations of TILs and vascular invasion, tumour differentiation, and tumour diameter.

        "The higher the stage of the cancer specimen, the lower the prevalence of TIL," he said, speculating that when the tumour is more advanced the immune response may be weaker. "I don't know if this is a cause and effect but this is an observation that has also been made in other reports."

        "We found there was a survival advantage that reached significance in squamous cell carcinoma if there was a presence of TIL (P =.03), although in adenocarcinoma it was just a trend (P =.03). Dr. Ruffini said his studies indicate that TIL activity occurs not only in and around the tumour but also works to combat cancer spread.

        "The study of TIL may be of help in providing prognostic information in addition to other parameters concerning tumour growth," he said.


        [Presentation title: Tumour Infiltrating Lymphocytes (TIL): Prevalence, Correlations and Prognostic Significance in Lung Neoplasms. Abstract 45]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send